Overexpression of TELO2 decreases survival in human high-grade gliomas.
Feng SW, Chen Y, Tsai WC, Chiou HC, Wu ST, Huang LC, Lin C, Hsieh CC, Yang YJ, Hueng DY.
Feng SW, et al. Among authors: chen y.
Oncotarget. 2016 Jul 19;7(29):46056-46066. doi: 10.18632/oncotarget.10021.
Oncotarget. 2016.
PMID: 27329594
Free PMC article.